Skip to main content

TNK1 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human TNK1 knockout HeLa cell line (AB264870), expandable thumbnail
  • Sanger Sequencing - Human TNK1 knockout HeLa cell line (AB264870), expandable thumbnail

Key facts

Cell type
HeLa
Species or organism
Human
Tissue
Cervix
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2

Alternative names

Recommended products

TNK1 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2.

Key facts

Cell type
HeLa
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2
Disease
Adenocarcinoma
Concentration
Loading...

Properties

Gene name
TNK1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type HeLa cell line (ab255448). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Tnk1 also known as Tyrosine kinase non-receptor 1 or ACK1 is a non-receptor tyrosine kinase with a molecular mass of approximately 72 kDa. This protein plays a role in signal transduction processes by phosphorylating various substrates. Tnk1 finds expression in different tissues with higher levels observed in the brain heart and testes. Its expression is vital for cellular communication and signaling cascades affecting a variety of cellular functions.

Biological function summary

Tnk1 is involved in regulatory mechanisms that control cell growth and apoptosis. Tnk1 is not part of a well-defined complex but it interacts with various cellular proteins affected by phosphorylation. It has a role in regulating signal pathways that influence gene expression contributing to cellular responses to external stimuli. The ability of Tnk1 to modulate these processes highlights its importance in maintaining cellular homeostasis.

Pathways

Tnk1 integrates into signaling networks such as the epidermal growth factor receptor (EGFR) pathway and Ras signaling pathway. In these pathways Tnk1 interacts with proteins like Epidermal Growth Factor Receptor (EGFR) and Ras assisting in the transduction of extracellular signals that govern cell proliferation and survival. The activity of Tnk1 within these pathways ensures that cells respond appropriately to environmental cues coordinating complex cellular responses.

Associated diseases and disorders

Tnk1 has been implicated in various cancers including lung and breast cancer. Abnormal expression or mutations in Tnk1 may lead to deregulated cell proliferation contributing to oncogenesis. Associations with other proteins like EGFR further define its role in cancer progression. Understanding the involvement of Tnk1 in these illnesses can provide insights into potential therapeutic approaches highlighting its relevance in disease mechanisms and treatment strategies.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human TNK1 knockout HeLa cell line (ab264870), expandable thumbnail

    Sanger Sequencing - Human TNK1 knockout HeLa cell line (ab264870)

    Allele-1: 1 bp deletion in exon 2.

  • Sanger Sequencing - Human TNK1 knockout HeLa cell line (ab264870), expandable thumbnail

    Sanger Sequencing - Human TNK1 knockout HeLa cell line (ab264870)

    Allele-2: Insertion of the selection cassette in exon 2.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com